HCA - CIK 0000860730
The table below shows HCA Healthcare, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $12.64B | $10.51B | $9.43B | $8.52B | $8.96B | $9.23B |
| Capital expenditure | $4.94B | $4.88B | $4.74B | $4.39B | $3.58B | $2.83B |
| Investing cash flow | -$4.99B | -$4.93B | -$5.32B | -$3.39B | -$2.64B | -$3.39B |
| Dividends paid | $679.00M | $690.00M | $661.00M | $653.00M | $624.00M |
HCA Healthcare, Inc. reported operating cash flow of $12.64B for fiscal year 2025. That is up 20.2% from $10.51B in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $5.65B (FY 2016) to $12.64B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $153.00M |
| Stock buybacks | $10.07B | $6.04B | $3.81B | $7.00B | $8.21B | $441.00M |
| Financing cash flow | -$8.55B | -$4.58B | -$4.09B | -$5.66B | -$6.66B | -$4.68B |